Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.

Suppr

超能文献

作者信息

Robinson G S, Aiello L P

机构信息

Hybridon, Inc., Cambridge, MA 02139, USA.

出版信息

Int Ophthalmol Clin. 1998 Spring;38(2):89-102.

PMID:9604739

Abstract

摘要

相似文献

Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.

Int Ophthalmol Clin. 1998 Spring;38(2):89-102.

Growth factors in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中的生长因子

Exp Diabesity Res. 2003 Oct-Dec;4(4):287-301. doi: 10.1155/EDR.2003.287.

[Role of insulin-like growth factor I in the development of diabetic retinopathy].[胰岛素样生长因子I在糖尿病视网膜病变发生发展中的作用]

Przegl Lek. 2003;60(9):588-92.

[Pathogenesis of diabetic retinopathy. II].

Klin Oczna. 1986 Aug;88(8):287-91.

[The role of angiogenic growth factors in the development of diabetic complications].[血管生成生长因子在糖尿病并发症发生发展中的作用]

Kardiol Pol. 2009 Jan;67(1):62-4.

Natural history of diabetic retinopathy.糖尿病视网膜病变的自然病程。

Isr J Med Sci. 1972 Aug-Sep;8(8):1311-5.

[Diabetic retinopathy and growth hormone secretion in 39 non insulin-dependant diabetic patients].39例非胰岛素依赖型糖尿病患者的糖尿病视网膜病变与生长激素分泌

Nouv Presse Med. 1973 Jul 7;2(27):1817-22.

Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.血管内皮生长因子与糖尿病视网膜病变：病理生理机制及治疗前景

Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):442-55. doi: 10.1002/dmrr.415.

Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy.生长因子和蛋白激酶C抑制剂作为糖尿病视网膜病变医学管理的新型疗法。

Eye (Lond). 2004 Feb;18(2):117-25. doi: 10.1038/sj.eye.6700585.

Observations on retinal neovascularization.

Trans New Orleans Acad Ophthalmol. 1983;31:82-8.

引用本文的文献

Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage.新型苯酞亚胺类似物治疗角膜新生血管和视网膜血管渗漏的疗效。

Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3630-3642. doi: 10.1167/iovs.18-24015.

VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.VEGF 介导体细胞 STAT3 激活通过下调局部促红细胞生成素表达抑制视网膜血管生成。

Am J Pathol. 2012 Mar;180(3):1243-1253. doi: 10.1016/j.ajpath.2011.11.031. Epub 2012 Jan 9.

Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).早产儿周边重度视网膜病变中无血管视网膜的发病机制及玻璃体新生血管形成的研究（美国眼科学会论文）

Trans Am Ophthalmol Soc. 2010 Dec;108:96-119.

Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.视网膜血管内皮生长因子与早产儿视网膜病变大鼠模型中无血管视网膜的关联

Arch Ophthalmol. 2010 Aug;128(8):1014-21. doi: 10.1001/archophthalmol.2010.158.

The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.氧应激对早产儿严重视网膜病变特征发展的影响：来自50/10氧诱导视网膜病变模型的认识

Doc Ophthalmol. 2010 Feb;120(1):25-39. doi: 10.1007/s10633-009-9181-x. Epub 2009 Jul 29.

Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.在早产儿视网膜病变大鼠模型中，抗VEGF中和抗体可减少玻璃体内新生血管形成，且可能不会干扰正在进行的视网膜内血管形成。

Mol Vis. 2008 Feb 11;14:345-57.

Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.激肽释放酶结合蛋白抑制视网膜新生血管形成并减少血管渗漏。

Diabetologia. 2003 May;46(5):689-98. doi: 10.1007/s00125-003-1085-9. Epub 2003 May 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验